Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 344

1.

Metformin monotherapy for type 2 diabetes mellitus.

Saenz A, Fernandez-Esteban I, Mataix A, Ausejo M, Roque M, Moher D.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD002966. Review. Update in: Cochrane Database Syst Rev. 2015;9:CD002966.

PMID:
16034881
2.

Sulphonylurea monotherapy for patients with type 2 diabetes mellitus.

Hemmingsen B, Schroll JB, Lund SS, Wetterslev J, Gluud C, Vaag A, Sonne DP, Lundstrøm LH, Almdal T.

Cochrane Database Syst Rev. 2013 Apr 30;(4):CD009008. doi: 10.1002/14651858.CD009008.pub2. Review. Update in: Cochrane Database Syst Rev. 2015;(7):CD009008.

PMID:
23633364
3.
4.

Insulin monotherapy compared with the addition of oral glucose-lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control.

Vos RC, van Avendonk MJ, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GE.

Cochrane Database Syst Rev. 2016 Sep 18;9:CD006992. [Epub ahead of print] Review.

PMID:
27640062
5.

Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus.

Fullerton B, Jeitler K, Seitz M, Horvath K, Berghold A, Siebenhofer A.

Cochrane Database Syst Rev. 2014 Feb 14;(2):CD009122. doi: 10.1002/14651858.CD009122.pub2. Review.

PMID:
24526393
6.
7.

Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus.

Hemmingsen B, Lund SS, Gluud C, Vaag A, Almdal TP, Hemmingsen C, Wetterslev J.

Cochrane Database Syst Rev. 2013 Nov 11;(11):CD008143. doi: 10.1002/14651858.CD008143.pub3. Review. Update in: Cochrane Database Syst Rev. 2015;(7):CD008143.

PMID:
24214280
8.

Oral antidiabetic agents: current role in type 2 diabetes mellitus.

Krentz AJ, Bailey CJ.

Drugs. 2005;65(3):385-411. Review.

PMID:
15669880
10.

Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus.

Hemmingsen B, Lund SS, Gluud C, Vaag A, Almdal T, Hemmingsen C, Wetterslev J.

Cochrane Database Syst Rev. 2011 Jun 15;(6):CD008143. doi: 10.1002/14651858.CD008143.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;11:CD008143.

PMID:
21678374
11.

[Metformin for type-2 diabetes mellitus. Systematic review and meta-analysis].

Sáenz Calvo A, Fernández Esteban I, Mataix Sanjuán A, Ausejo Segura M, Roqué M, Moher D.

Aten Primaria. 2005 Sep 15;36(4):183-91. Review. Spanish.

12.

The effect of metformin on blood pressure, plasma cholesterol and triglycerides in type 2 diabetes mellitus: a systematic review.

Wulffelé MG, Kooy A, de Zeeuw D, Stehouwer CD, Gansevoort RT.

J Intern Med. 2004 Jul;256(1):1-14. Review.

13.

Interventions for latent autoimmune diabetes (LADA) in adults.

Brophy S, Davies H, Mannan S, Brunt H, Williams R.

Cochrane Database Syst Rev. 2011 Sep 7;(9):CD006165. doi: 10.1002/14651858.CD006165.pub3. Review.

PMID:
21901702
14.

Colesevelam for type 2 diabetes mellitus.

Ooi CP, Loke SC.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD009361. doi: 10.1002/14651858.CD009361.pub2. Review.

PMID:
23235674
15.

Meglitinide analogues for type 2 diabetes mellitus.

Black C, Donnelly P, McIntyre L, Royle PL, Shepherd JP, Thomas S.

Cochrane Database Syst Rev. 2007 Apr 18;(2):CD004654. Review.

PMID:
17443551
16.

Alpha-glucosidase inhibitors for type 2 diabetes mellitus.

Van de Laar FA, Lucassen PL, Akkermans RP, Van de Lisdonk EH, Rutten GE, Van Weel C.

Cochrane Database Syst Rev. 2005 Apr 18;(2):CD003639. Review.

PMID:
15846673
17.

Comparison of Clinical Outcomes and Adverse Events Associated With Glucose-Lowering Drugs in Patients With Type 2 Diabetes: A Meta-analysis.

Palmer SC, Mavridis D, Nicolucci A, Johnson DW, Tonelli M, Craig JC, Maggo J, Gray V, De Berardis G, Ruospo M, Natale P, Saglimbene V, Badve SV, Cho Y, Nadeau-Fredette AC, Burke M, Faruque L, Lloyd A, Ahmad N, Liu Y, Tiv S, Wiebe N, Strippoli GF.

JAMA. 2016 Jul 19;316(3):313-24. doi: 10.1001/jama.2016.9400.

PMID:
27434443
18.
19.

Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis.

Karagiannis T, Paschos P, Paletas K, Matthews DR, Tsapas A.

BMJ. 2012 Mar 12;344:e1369. doi: 10.1136/bmj.e1369.

PMID:
22411919
20.

Psychological and pharmacological interventions for depression in patients with diabetes mellitus and depression.

Baumeister H, Hutter N, Bengel J.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD008381. doi: 10.1002/14651858.CD008381.pub2. Review.

PMID:
23235661

Supplemental Content

Support Center